ClassID:

20207

A61K31/095 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients Sulfur, selenium, or tellurium compounds, e.g. thiols

Recent Application in this class:
#301
20090247477
2009-10-01

Methods of suppressing uv light-induced skin carcinogenesis

#302
20090239817
2009-09-24

ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS

#303
20090232827
2009-09-17

Compositions and methods of use of compounds to increase cancer patient survival time

#304
20090192212
2009-07-30

Dithiol compounds, derivatives, and treatment of presbyopia

#305
20090181081
2009-07-16

Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance

#306
20090176826
2009-07-09

Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects

#307
20090136599
2009-05-28

HOMEOPATHIC COMPOSITION AND KIT THEREFORE

#308
20090131391
2009-05-21

INHIBITOR FOR DIFFERENTIATION OF HEMATOPOIETIC PRECURSOR CELLS

#309
20090111779
2009-04-30

Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis

#310
20090110740
2009-04-30

Materials and methods for modulating metabolism

#311
20090105313
2009-04-23

Method for treating a keratoconjunctival disorder

#312
20090028831
2009-01-29

STEM CELL REGULATOR, COMPOSITIONS AND METHODS OF USE

#313
20090023793
2009-01-22

Inhibitors of melanocyte tyrosinase as topical skin lighteners

#314
20090023792
2009-01-22

Inhibitors of melanocyte tyrosinase as topical skin lighteners

#315
20090011051
2009-01-08

Methods, Compositions and Articles of Manufacture for HIF Modulating Compounds

#316
20080306148
2008-12-11

ANTI-CANCER COMPOSITIONS AND METHODS

#317
20080280985
2008-11-13

Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of Diabetes

#318
20080275100
2008-11-06

Propofol analogs, process for their preparation, and methods of use

#319
20080255185
2008-10-16

Small-molecule modulators of TRP-P8 activity

#320
20080249185
2008-10-09

Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy

#321
20080220095
2008-09-11

Red blood cells loaded with s-nitrosothiol and uses therefor

#322
20080194518
2008-08-14

Antimicrobial Compositions

#323
20080171726
2008-07-17

Methods, Compositions and Articles of Manufacture for Enhancing Survivability of Cells, Tissues, Organs, and Organisms

#324
20080171725
2008-07-17

Methods, Compositions and Articles of Manufacture for Enhancing Survivability of Cells, Tissues, Organs, and Organisms

#325
20080171093
2008-07-17

Methods, Compositions and Devices for Inducing Stasis in Cells, Tissues, Organs, and Organisms

#326
20080170997
2008-07-17

Compositions for the treatment and prevention of cancer

#327
20080167336
2008-07-10

Azaadamantane derivatives and methods of use

#328
20080139512
2008-06-12

Method for minimizing or avoiding adverse effects of vesicants

#329
20080132568
2008-06-05

COMPOUNDS WITH ANTI-ANDROGENIC ACTIVITY AND THE USE THEREOF

#330
20080125486
2008-05-29

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ

#331
20080114060
2008-05-15

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#332
20080113948
2008-05-15

Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Psoriasis

#333
20080113947
2008-05-15

Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Rosacea

#334
20080102074
2008-05-01

Trace elements

#335
20080102034
2008-05-01

PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS

#336
20080102033
2008-05-01

PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS

#337
20080085329
2008-04-10

Methods, Compositions and Devices for Inducing Stasis in Cells, Tissues, Organs, and Organisms

#338
20080064665
2008-03-13

Combination approaches to cancer treatment

#339
20080045475
2008-02-21

Elemental cellular therapy is a genetic, cellular and disease-modifying therapy which enhances the systemic conduct of genetic and cellular transmethylation activity resulting in enhancement of concerted genetic and cellular metabolic, physiologic and homeostatic processes

#340
20080033019
2008-02-07

Cholesterol lowering drug combination

#341
20080015171
2008-01-17

Method for increasing absorption of steroid hormones

#342
20080004255
2008-01-03

Methods and compositions for altering cell function

#343
20070298081
2007-12-27

Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy

#344
20070282012
2007-12-06

Reagent for Lacrimation Examination and Method of Lacrimation Examination

#345
20070275878
2007-11-29

NO-modified hemoglobins and uses therefor

#346
20070275876
2007-11-29

Method to increase the bioavailability of cysteine

#347
20070265334
2007-11-15

Sulfonated compounds and compositions for treating amyloidosis

#348
20070258996
2007-11-08

Antimicrobial compositions

#349
20070248676
2007-10-25

Use of nitric oxide adducts

#350
20070231371
2007-10-04

Nutritional system and methods for increasing longevity

#351
20070225238
2007-09-27

Inhibitors of carbonyl reductase for treatment using anthracyclines

#352
20070224290
2007-09-27

Nutrient supplements and methods for treating autism and for preventing the onset of autism

#353
20070224275
2007-09-27

Selenium-based biocidal formulations and methods of use thereof

#354
20070219268
2007-09-20

Anti-cancer activity augmentation compounds and formulations and methods of use thereof

#355
20070185217
2007-08-09

Propofol analogs, process for their preparation, and methods of use

#356
20070154581
2007-07-05

Composition and method for enhancing or stimulating the immune system

#357
20070149618
2007-06-28

Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis

#358
20070134277
2007-06-14

Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms

#359
20070078113
2007-04-05

Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms

#360
20070059341
2007-03-15

Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy

#361
20070026090
2007-02-01

Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium

#362
20070020343
2007-01-25

Nutrient supplements and methods for treating autism and for preventing the onset of autism

#363
20060257987
2006-11-16

Ppar modulators

#364
20060251597
2006-11-09

ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE

#365
20060235047
2006-10-19

Antibacterial compounds and uses thereof

#366
20060217381
2006-09-28

Methods and compositions for specific inhibition of protein splicing by small molecules

#367
20060167095
2006-07-27

Method for treating amyloidosis

#368
20060166957
2006-07-27

Methods of treating obesity and related disorders using tellurium selenium compounds

#369
20060166281
2006-07-27

Potent, selective and non toxic c-kit inhibitors

#370
20060159632
2006-07-20

Drug formulation for mouth or pharynx comprising local anesthetic

#371
20060153931
2006-07-13

Prevention of flap necrosis in plastic surgery

#372
20060148898
2006-07-06

Curing and prophylactic agent applied during the use of alcohol and psychoactive substances

#373
20060105960
2006-05-18

Selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics

#374
20060058380
2006-03-16

Novel aminobenzophenone compounds

#375
20060024283
2006-02-02

Red blood cells loaded with -nitrosothiol and uses therefor

#376
20050250672
2005-11-10

Preparation for the prophylaxis of restenosis

#377
20050245433
2005-11-03

Methods for modulating metabolism

#378
20050202101
2005-09-15

Method and composition for preventing or reducing the symptoms of insulin resistance syndrome

#379
20050197399
2005-09-08

Method of augmenting the antitumor activity of anticancer agents

#380
20050176687
2005-08-11

Use of tyrosine kinase inhibitors for treating autoimmune diseases

#381
20050176678
2005-08-11

Compounds and method for coating surfaces in a haemocompatibe manner

#382
20050152859
2005-07-14

Inhibitors of melanocyte tyrosinase as topical skin lighteners

#383
20050143473
2005-06-30

Methods for treating allergy

#384
20050124590
2005-06-09

Compositions and methods for inhibiting NF-κB mediated tumorigenicity and adhesion dependent survival of cancer cells

#385
20050106228
2005-05-19

Compositions for the treatment and prevention of cancer

#386
20050101522
2005-05-12

Preparation for the prophylaxis of restenosis

#387
20050100614
2005-05-12

Method and composition for preventing or reducing the symptoms of insulin resistance syndrome

#388
20050090551
2005-04-28

Therapeutic use of methionine for the treatment or prevention of mucositis

#389
20050084458
2005-04-21

Compositions for the treatment and prevention of cancer

#390
20050059688
2005-03-17

Use of tyrosine kinase inhibitors for treating inflammatory diseases

#391
20050054617
2005-03-10

Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis

#392
20050032753
2005-02-10

Substituted phenol compounds useful for anesthesia and sedation

#393
20050026852
2005-02-03

Method of augmenting the antitumor activity of anticancer agents

#394
19011111
2026-03-10

Stable, highly pure L-cysteine compositions for injection and methods of use

#395
19001318
2026-03-10

Stable, highly pure L-cysteine compositions for injection and methods of use

#396
18651036
2025-01-07

Stable, highly pure L-cysteine compositions for injection and methods of use

#397
18651026
2024-12-24

Stable, highly pure L-cysteine compositions for injection and methods of use

#398
18520172
2024-04-30

Stable, highly pure L-cysteine compositions for injection and methods of use

#399
18332677
2023-11-28

Stable, highly pure L-cysteine compositions for injection and methods of use

#400
18067605
2023-06-20

Stable, highly pure L-cysteine compositions for injection and methods of use

#401
18067397
2023-05-16

Stable, highly pure L-cysteine compositions for injection and methods of use

#402
18067287
2023-05-09

Stable, highly pure L-cysteine compositions for injection and methods of use

#403
18049468
2023-10-10

Antitoxins to brevetoxin

#404
17950979
2023-06-27

Stable, highly pure l-cysteine compositions for injection and methods of use

#405
17950964
2023-06-13

Stable, highly pure L-cysteine compositions for injection and methods of use

#406
17839147
2025-01-21

Composition and method for preventing long-term COVID-19 morbidity

#407
17188922
2022-11-29

Stable, highly pure L-cysteine compositions for injection and methods of use

#408
17164263
2022-11-29

Stable, highly pure L-cysteine compositions for injection and methods of use

#409
16773563
2020-05-19

Stable, highly pure L-cysteine compositions for injection and methods of use

#410
16665702
2020-03-10

Stable, highly pure L-cysteine compositions for injection and methods of use

#411
16248460
2019-11-19

Stable, highly pure L-cysteine compositions for injection and methods of use

#412
16228868
2020-09-22

Method for treating a tooth using selenite

#413
13659501
2014-07-08

Anti-cancer compositions and methods